Goldman Sachs ActiveBeta International Equity ETF (GSIE)
| Assets | $5.98B |
| Expense Ratio | 0.25% |
| PE Ratio | 16.08 |
| Forward PE | 13.84 |
| Shares Out | 128.80M |
| Dividend | $1.21 (2.63%) |
| Ex-Dividend Date | Sep 24, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | 42.18% |
| Volume | 206,657 |
| Open | 46.35 |
| Previous Close | 46.28 |
| Day's Range | 46.09 - 46.35 |
| 52-Week Low | 40.05 |
| 52-Week High | 48.49 |
| Beta | 0.78 |
| Holdings | 632 |
| Inception Date | Nov 6, 2015 |
About GSIE
Fund Home PageThe Goldman Sachs ActiveBeta International Equity ETF (GSIE) is an exchange-traded fund that mostly invests in stocks across the whole market. The fund tracks an index of stocks in developed markets outside of the US comprising four sub-indices: value, momentum, quality and low volatility. The index uses multiple factors to pick stocks, and each sub-index receives equal weight GSIE was launched on Nov 6, 2015 and is issued by Goldman Sachs.
Top 10 Holdings
10.93% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 2.23% |
| Roche Holding AG | ROP | 1.16% |
| Royal Bank of Canada | RY | 1.14% |
| Novartis AG | NOVN | 1.05% |
| Advantest Corporation | 6857 | 1.04% |
| HSBC Holdings plc | HSBA | 0.99% |
| The Toronto-Dominion Bank | TD | 0.87% |
| Recruit Holdings Co., Ltd. | 6098 | 0.85% |
| Shell plc | SHEL | 0.81% |
| AstraZeneca PLC | AZN | 0.80% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 24, 2026 | $0.260 | Sep 30, 2026 |
| Jun 24, 2026 | $0.5881 | Jun 30, 2026 |
| Mar 25, 2026 | $0.1433 | Mar 31, 2026 |
| Dec 23, 2025 | $0.2187 | Dec 30, 2025 |
| Sep 24, 2025 | $0.22414 | Sep 30, 2025 |
| Jun 24, 2025 | $0.56325 | Jun 30, 2025 |
Performance
GSIE had a total return of 14.65% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.58%.
News
GSIE Benefits From Surging Interest in International Equities
Investor interest in international equities has been one of the prevailing stories of 2026, due to years of domestic growth and the recent outsized dominance of U.S. megacap technology stocks.